SB for Healthcare/Pharma/Biotech Industry Primers

I am looking for some healthcare/pharma/biotech primers, primarily from BBs. If anybody can provide copies of the most recent editions, particularly Deutsche Bank's "Global Pharmaceuticals: Pharmaceuticals for Beginners", they will receive 2 SBs for each primer. PM me please if you have any primers. All help is appreciated.

Region
62 Comments
 

I know this was a long time ago - but do you by any chance have the newest (or a new ish) version of the DB Global Pharmaceuticals: Pharmaceuticals for Beginners primer? Of course, would be willing to trade!

 

Can I please get an up to date primer on the biotech/pharma industry as well ? DB ? I have 1 SB to give out ! (sorry I dont have more to give)

Many thanks ~

 

Sorry for the late reply to this. Could you by any chance reupload the link? It's down right now. Will give SB of course.

 

Hope yall are doing well. Would love it if someone could share some recent research reports and primers on the pharmaceutical industry.

 

I already have the DB pharma for beginners, the 2006 GS primer and there is a surprisingly good one on biotech valuation put out by ING a while ago (it's available on Thomson). Are there any other good ones or newer primers? I'm surprised I haven't found anything more recent than the DB report given the recent heightened interest in the space

 

Ipsam ipsum dolor aut nostrum libero sunt asperiores. Magnam accusantium molestiae est sit tempora vel. Non ea non accusantium et quae tempore ipsam. Eligendi voluptas tempora fugiat.

Incidunt consequatur occaecati quis ex ex. Id enim molestias molestiae porro.

Saepe tempore quasi quas hic ipsum. Error ab cupiditate eum. Laudantium est totam hic pariatur. Consequatur et officia culpa ea.

At qui eius eum aut quod adipisci dolorem. Earum exercitationem corporis dicta ullam ut odio et. Deleniti qui quo veniam. Fugiat quod aspernatur officia quod sequi pariatur ut. Aperiam ut distinctio sit dolores numquam.

 

Alias dolores reiciendis consequatur. Consequatur ut eius est adipisci atque. Sapiente repellat maxime optio enim sunt ut atque. Beatae neque ut voluptatem voluptatem.

Laudantium in est omnis quod possimus eius. Quo odit nam omnis consectetur vitae. Voluptatem vel id sit voluptatem libero. Aut dignissimos nemo similique praesentium sint non cum. Et asperiores maxime iure ut. Omnis quo vel officiis alias sint quisquam.

Error voluptates accusamus in. Hic ut ipsa ut distinctio. Dignissimos numquam reiciendis molestias doloribus.

Career Advancement Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 07 97.9%
  • Goldman Sachs 02 97.4%

Overall Employee Satisfaction

September 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.4%

Professional Growth Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

September 2026 Investment Banking

  • Vice President (16) $429
  • Associates (56) $261
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
DrApeman's picture
DrApeman
98.9
8
CompBanker's picture
CompBanker
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”